The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-((5-(Pyridin-4-yl)-1,3,4-thiadiazol-2-yl)carbamoyl)quinoline-2-carboxylic Acid ID: ALA3613462
PubChem CID: 122189016
Max Phase: Preclinical
Molecular Formula: C18H11N5O3S
Molecular Weight: 377.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1cc(C(=O)Nc2nnc(-c3ccncc3)s2)c2ccccc2n1
Standard InChI: InChI=1S/C18H11N5O3S/c24-15(21-18-23-22-16(27-18)10-5-7-19-8-6-10)12-9-14(17(25)26)20-13-4-2-1-3-11(12)13/h1-9H,(H,25,26)(H,21,23,24)
Standard InChI Key: KNTMNLHAKOPLIN-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2995 -2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 -3.7467 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2613 -3.5999 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6034 -5.2475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8169 -6.1073 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3534 -7.5339 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8534 -7.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3899 -6.1074 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.9713 -8.7481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4757 -10.1554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5053 -11.2992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9705 -11.0306 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4758 -9.6183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5053 -8.4745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8911 1.5017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9314 0.9035 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8894 2.7017 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
7 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 1 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
25 26 1 0
25 27 2 0
9 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 377.39Molecular Weight (Monoisotopic): 377.0583AlogP: 3.10#Rotatable Bonds: 4Polar Surface Area: 117.96Molecular Species: ACIDHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 0.77CX Basic pKa: 4.05CX LogP: 1.85CX LogD: -0.86Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.56Np Likeness Score: -1.70
References 1. Olson ME, Abate-Pella D, Perkins AL, Li M, Carpenter MA, Rathore A, Harris RS, Harki DA.. (2015) Oxidative Reactivities of 2-Furylquinolines: Ubiquitous Scaffolds in Common High-Throughput Screening Libraries., 58 (18): [PMID:26358009 ] [10.1021/acs.jmedchem.5b00930 ]